Tirzepatide CAS: 2023788-19-2 Chaw Tsim Khoom Chaw Tsim Khoom Duab Tshwj Xeeb

Tirzepatide CAS: 2023788-19-2 Chaw Tsim Khoom Siv

Tirzepatide tau tsim los ua ib qho agonist ob qho tib si rau ob qho tib si GLP-1 thiab gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Zoo ib yam li GLP-1, GIP yog ib qho incretin hormone uas ua haujlwm los ua kom insulin secretion. Tirzepatide nyob rau theem 3 kev tsim kho rau cov neeg laus uas rog dhau lossis rog dhau nrog qhov hnyav-cuam tshuam comorbidity thiab tam sim no nyob rau hauv kev tshuaj xyuas kev cai lij choj ua kev kho mob rau cov neeg laus uas muaj hom 2 ntshav qab zib. Nws kuj tseem tab tom kawm ua ib qho kev kho mob rau cov kab mob steatohepatitis uas tsis yog cawv (NASH) thiab lub plawv tsis ua haujlwm nrog kev khaws cia ejection fraction (HFpEF).

Txiav txim los yog Thov Kev Hais Nqe

Cov Lus Qhia Txog Khoom

Cov Cim Npe Khoom

Daim Ntawv Thov thiab Cov Nyhuv

Tirzepatide siv nrog kev noj zaub mov zoo thiab kev tawm dag zog kom tswj tau cov ntshav qab zib siab rau cov neeg uas muaj ntshav qab zib hom 2. Kev tswj cov ntshav qab zib siab pab tiv thaiv kev puas tsuaj rau lub raum, dig muag, teeb meem hlab ntsha, poob ceg, thiab teeb meem kev ua haujlwm ntawm kev sib deev. Tirzepatide muaj kev sib raug zoo dua rau GIP receptors dua li GLP-1 receptors, thiab tus cwj pwm dual agonist no tau pom tias ua rau muaj kev txo qis ntawm hyperglycemia piv rau tus xaiv GLP-1 receptor agonist. Cov kev tshawb fawb qhia tau tias qhov no yog vim tirzepatide ua raws li cov haujlwm ntawm GIP ntuj ntawm GIP receptor.

Qauv Khoom

Khoom Ntim:

Cov Lus Qhia Ntxiv:

Kev sau ua ke	Tsis yog
Kev Ntsuas	99%
Qhov tsos	Hmoov dawb
CAS Nr.	2023788-19-2
Ntim khoom	25KG
Lub Neej Txee	2 xyoos
Kev Khaws Cia	Khaws cia rau qhov chaw txias thiab qhuav
Daim Ntawv Pov Thawj	ISO.